UnitedHealth (UNH) is a major healthcare and insurance company with divisions including UnitedHealthcare and Optum. The stock has struggled, down 39% YTD, but rebounded 12% after Berkshire Hathaway increased its stake. Second quarter 2025 results saw a decrease in earnings and a rise in revenue. The company forecasts adjusted net EPS of at least $16 for 2025. Soros Fund Management and Appaloosa Management increased their holdings in UnitedHealth significantly. Analysts have given UnitedHealth a “Moderate Buy” rating with an average price target of $310.19. This signals renewed investor confidence despite challenges.

Read more at Yahoo Finance: George Soros Is Betting Big on Beaten-Down UnitedHealth Stock. Should You?